Solventum faces tariff margin pressure, completes $4B divestiture, launches buybacks

Filed May 5, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 9, 2025 · ~1 min read

Key Changes

• high

  Tariff costs squeezed product margins in Q1 2026, with Supreme Court ruling IEEPA tariffs unlawful but refund timing uncertain. Company has not recorded any benefit from potential refunds due to administrative uncertainty.

  MD&A: Cost of Product verify on EDGAR →
• high

  Completed $4 billion sale of Purification and Filtration business in September 2025, excluding drinking water filtration. Proceeds funded debt paydown, reducing interest expense year-over-year.

  MD&A: Divestitures verify on EDGAR →
• high

  Launched $1 billion share repurchase program in November 2025, buying back $67 million of stock in Q1 2026. First capital return to shareholders since spin-off from 3M.

  MD&A: Capital Allocation verify on EDGAR →